Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company ConjuChem Biotechnologies Inc.
DescriptionC34 peptide with conjugate-drug affinity complex (PC-DAC) technology
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV infection/AIDS
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today